Molecular docking studies shows tivozanib and lapatinib as potential inhibitors of EML4-ALK translocation mediated fusion protein in non small cell lung cancer.

Ramshankar, Vijayalakshmi; Yegnaswamy, Subha; P, Kumarasamy; Arvind, Krishnamurthy

Ramshankar, Vijayalakshmi; Yegnaswamy, Subha; P, Kumarasamy; Arvind, Krishnamurthy.

Afiliação

Ramshankar V; Department of Preventive Oncology, Cancer Institute (WIA), Adyar, Chennai.
Yegnaswamy S; Department of Bioinformatics, Madras Veterinary College, Vepery, Chennai.
P K; Department of Bioinformatics, Madras Veterinary College, Vepery, Chennai.
Arvind K; Department of Surgical Oncology, Cancer Institute (WIA), Adyar, Chennai.

Bioinformation ; 10(10): 658-63, 2014.

Article em En | MEDLINE | ID: mdl-25489176

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article